Nivolumab induced remitting seronegative symmetrical synovitis with pitting edema in a patient with melanoma: a case report

BACKGROUND: Novel immune checkpoint inhibitors have been often utilized for different types of malignancies as salvage therapy with varying success. One obstacle to immune checkpoint inhibitor use is the higher incidence of immune-mediated side effects that can prompt discontinuation of therapy. Rem...

Descripción completa

Detalles Bibliográficos
Autores principales: Ngo, Linh, Miller, Eric, Valen, Peter, Gertner, Elie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389137/
https://www.ncbi.nlm.nih.gov/pubmed/29478412
http://dx.doi.org/10.1186/s13256-018-1579-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389137/
https://www.ncbi.nlm.nih.gov/pubmed/29478412
http://dx.doi.org/10.1186/s13256-018-1579-1

Ejemplares similares